Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 14, 2023

BUY
$239.75 - $277.0 $47,230 - $54,569
197 Added 6.44%
3,257 $820,000
Q2 2022

Jul 14, 2022

SELL
$237.11 - $299.66 $6,876 - $8,690
-29 Reduced 0.94%
3,060 $777,000
Q1 2022

Apr 28, 2022

SELL
$257.27 - $315.76 $25,727 - $31,576
-100 Reduced 3.14%
3,089 $906,000
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $381,366 - $465,734
-1,401 Reduced 30.52%
3,189 $971,000
Q2 2021

Aug 11, 2021

SELL
$225.08 - $271.69 $231,832 - $279,840
-1,030 Reduced 18.33%
4,590 $1.23 Million
Q1 2021

May 11, 2021

BUY
$212.38 - $245.9 $19,114 - $22,131
90 Added 1.63%
5,620 $1.27 Million
Q3 2020

Oct 19, 2020

SELL
$177.16 - $215.33 $34,546 - $41,989
-195 Reduced 3.41%
5,530 $1.19 Million
Q2 2020

Jul 22, 2020

SELL
$128.7 - $176.83 $81,724 - $112,287
-635 Reduced 9.98%
5,725 $1.01 Million
Q1 2020

Apr 22, 2020

SELL
$121.39 - $169.05 $125,638 - $174,966
-1,035 Reduced 14.0%
6,360 $880,000
Q4 2019

Feb 07, 2020

SELL
$133.47 - $153.48 $301,642 - $346,864
-2,260 Reduced 23.41%
7,395 $1.14 Million
Q3 2019

Oct 24, 2019

SELL
$135.4 - $146.47 $5,416 - $5,858
-40 Reduced 0.41%
9,655 $1.39 Million
Q2 2019

Jul 16, 2019

SELL
$124.88 - $143.73 $9,990 - $11,498
-80 Reduced 0.82%
9,695 $1.39 Million
Q4 2018

Jan 28, 2019

BUY
$94.85 - $109.54 $927,158 - $1.07 Million
9,775 New
9,775 $1.01 Million
Q4 2017

Feb 12, 2018

SELL
$85.26 - $94.62 $961,306 - $1.07 Million
-11,275 Closed
0 $0
Q3 2017

Nov 03, 2017

BUY
$79.29 - $88.45 $893,994 - $997,273
11,275
11,275 $967,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Spectrum Asset Management, Inc. Portfolio

Follow Spectrum Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spectrum Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Spectrum Asset Management, Inc. with notifications on news.